SCHEMBL5822665

SCHEMBL5822665

Cc1cccc(CCOC2CCC(Nc3nccc4[nH]ncc34)CC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
GPR6 P46095 4/20 0.38
ROCK2 O75116 3/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BRD4 O60885 1/20 0.37
ATAD2 Q6PL18 1/20 0.37
UTS2R Q9UKP6 1/20 0.36
LRRK2 Q5S007 1/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 2/20 0.34
ROCK1 Q13464 2/20 0.34
ARHGDIA P52565 1/20 0.34
HPGDS O60760 1/20 0.34
PAK1 Q13153 2/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14010154 0.88 CYP1A2 (0.57) CYP1A2LMNAHPGDSPAK1TSHR
SCHEMBL5006065 0.88 CYP1A2 (0.57) CYP1A2LMNAHPGDSPAK1TSHR
SCHEMBL5006068 0.88 CYP1A2 (0.57) CYP1A2LMNAHPGDSPAK1TSHR
SCHEMBL6533753 0.82 GRIN2B (0.40) CYP1A2ROCK2UTS2RLRRK2ROCK1
SCHEMBL8292778 0.82 CYP1A2 (0.55) CYP1A2LMNAHPGDSPAK1TSHR
SCHEMBL5797610 0.82 ROCK2 (0.39) CYP1A2GPR6ROCK2ALDH1A1MEN1
SCHEMBL5006424 0.76 MAPK1 (0.49) CYP1A2HPGDSPAK1MAPK1HTT
SCHEMBL14010151 0.76 MAPK1 (0.49) CYP1A2HPGDSPAK1MAPK1HTT
SCHEMBL5006427 0.76 MAPK1 (0.49) CYP1A2HPGDSPAK1MAPK1HTT
SCHEMBL5003519 0.75 PAK1 (0.54) CYP1A2HPGDSPAK1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656379-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2006-05-17 EP disclosed
WO-2005019221-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2005-03-03 WO disclosed